David Campen, MD, Rheumatology, Palo Alto, CA

DavidH.CampenMDFACP, FACR

Rheumatology Palo Alto, CA

Retired

Dr. Campen is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Campen's full profile

Already have an account?

Education & Training

  • University of Southern California - LAC+USC Medical Center
    University of Southern California - LAC+USC Medical CenterFELLOWSHIP
  • University of Southern California - LAC+USC Medical Center
    University of Southern California - LAC+USC Medical CenterRESIDENCY
  • Tulane University School of Medicine
    Tulane University School of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1984 - 2018
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Fellow (FACP) American College of Physicians, 2006
  • Fellow (FACR) American College of Rheumatology
  • Top MD Consumers Checkbook

Publications & Presentations

PubMed

Journal Articles

  • Risk of Acute Myocardial Infarction and Sudden Cardiac Death with Use of COX-2 Selective and Non-Selective NSAIDs  
    Graham D, Campen D, Cheetham C, Hui R, Spence M, Ray WA, Lancet

Press Mentions

  • At F.D.A., Strong Drug Ties and Less Monitoring
    At F.D.A., Strong Drug Ties and Less MonitoringDecember 06, 2004
  • One Lesson from Vioxx: Approach New Drugs with Caution
    One Lesson from Vioxx: Approach New Drugs with CautionOctober 05, 2004

Committees

  • Member/chairman, USP Model Formulary Committee

Professional Memberships

Other Languages

  • Sign Language (American)